Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

Q4:16 Healthcare Deals Continue Downward Drift

by | Jan 27, 2017 4:37 pm | Healthcare Market Updates

Deal volume has trended downward in 2016, after spiking in the second quarter with a total of 421 deals. The third quarter logged 375 deals, and the fourth quarter’s total slipped 2%, to 366 transactions. These are not major shifts, and every quarter since Q1:14 has reported totals of greater than 350 transactions. We may be witnessing the beginning of a real downward trend, if enough investors are spooked by the Trump administration and Congress’s efforts to repeal and replace the Affordable Care Act. No replacement plan has been approved as of this writing a week after the inauguration of Donald Trump, although some senators have put forward their own plans to be debated. Healthcare... Read More »
Werfen Life Divests to Focus on the Hemostasis Market

Werfen Life Divests to Focus on the Hemostasis Market

by | Jan 27, 2017 4:15 pm | Biotechnology, Private Equity

The growing prevalence of autoimmune and blood disorders has put a spotlight on the science of hemostasis, the process of stopping bleeding and keeping blood within the damaged blood vessel. The coagulation/hemostasis analyzer market is expected to reach $4.84 billion by 2021, according to a report from MarketsandMarkets. Among the products, clinical laboratory analyzers are expected to account for the largest share of the market. Some big name players are already strengthening their hemostasis portfolios. In December 2015, Mallinckrodt plc (NYSE: MNK) purchased a global portfolio of three hemostasis products from The Medicines Company (NASDAQ: MDCO) for an upfront payment of $175... Read More »

Behavioral Health Company Goes Public after Acquisition

by | Jan 20, 2017 8:45 pm | Behavioral Health Care, Private Equity

The Behavioral Health sector isn’t charging into the New Year. Only two deals have been announced in the first three weeks of January, but one of those is unusual for the sector. On January 11, 2017, Global Partner Acquisition Corp. (NASDAQ: GPAC), a blank-check company formed for the purpose of effecting a business combination, merged with Alabama-based Sequel Youth and Family Services, a portfolio company of Levine Leichtman Capital Partners. Sequel Youth and Family Services now operates 44 residential and community-based programs in 19 states that offer diversified behavioral health services for children, adolescents and adults with behavioral, emotional or physical challenges. In March... Read More »

Urgent Care Centers May Benefit from ACA Repeal

by | Jan 20, 2017 7:38 pm | Other Services, Urgent Care Centers

Last week, the Urgent Care Association of America (UCAOA) released its annual Benchmarking Report. In it was the finding that the number of urgent care centers increased 10% in 2016, to 7,357 centers. Looking through our database, it’s obvious that the majority of that year-over-year growth in urgent care centers was de novo, not from mergers and acquisitions. Here’s how M&A in the urgent care segment has played out since 2010, the year the Affordable Care Act was signed. Urgent Care Center Deals, 2010 to 2016 YearNumber of DealsTotal $ Spent 201612N/A 201517$1.06 billion 20149$2.2 million 20132N/A 201210$7.8 million 20114N/A 20102$805 million #rowspan#Source: HealthCareMandA.com Only... Read More »

Pharmaceutical Deals Celebrate the New Year

by | Jan 19, 2017 3:57 pm | Pharmaceuticals

The Pharmaceutical sector hasn’t wasted any time getting busy in the New Year. As of January 18, 2017, 10 pharma deals have been announced, with disclosed prices totaling $7.18 billion. Of course, the annual JP Morgan Healthcare Summit, held this year from January 9 to January 13, helped to boost the announcements. The largest deal so far was Takeda Pharmaceutical Co. Ltd.’s (OTCQB: TKPYY) $4.67 billion ($24.00 per share) takeover of ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA). ARIAD is an oncology company that discovers, develops and commercializes drugs for patients with rare cancers. A large motivator for the deal was to gain access to Iclusig® (ponatinib), a globally commercialized... Read More »

Bain Capital Expands its Pediatric Home Health Platform

by | Jan 18, 2017 6:28 pm | Home Health & Hospice, Private Equity

In less than a month, Bain Capital Private Equity has built a major pediatric home health care platform. It began on December 19,  2016, with Bain’s announcement that it was acquiring Dallas, Texas-based Epic Health Services, from Webster Capital. On January 17, 2017, the global private equity firm announced a deal for Atlanta, Georgia-based PSA Healthcare, sold by J.H. Whitney Capital Partners. Financial terms were not disclosed in either deal. J.H. Whitney acquired PSA Healthcare, then known as Pediatric Services of America, Inc., in March 2015, for an undisclosed price. PSA specialized in caring for medically fragile children at home, caring for more than 2,500 patients through 65... Read More »

December 2016 Didn’t Deliver a Year-End Boost

by | Jan 13, 2017 4:37 pm | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Medical Devices, Pharmaceuticals, Physician Medical Groups, Private Equity, Rehabilitation

The final month of the fourth quarter is typically a busy one for deal makers in all industries. Last year, some health care deal makers apparently got a rest. Deal volume in December 2016 was an anemic 119 transactions, compared with 131 deals in November and 148 in December 2015. The Services sectors accounted for 55% of the deals in December, which is on the low side. Consider that, in November, Services accounted for 69% of the month’s transactions, and even 70% of the total in December 2015. Spending on those deals reached $15.4 billion, a relatively modest amount until it is compared with November’s $8.7 billion total (+78%) and December 2015’s $12.3 billion total (+26%). Suddenly,... Read More »

Good-Bye, ACA. Now What?

by | Jan 12, 2017 8:00 am | Biotechnology, eHealth, Home Health & Hospice, Hospitals, Long-Term Care

And so it begins. A new year, a new administration, and a foreboding that things can and will go wildly out of control in the healthcare industry, as the new administration dismantles the Affordable Care Act and doesn’t bother to replace it. Judging from the market’s behavior since the November 8 election, the notion that a Hillary Clinton victory was “baked in” to every healthcare deal doesn’t hold. Certainly some deals may have been put on hold following Donald Trump’s election, but 2016 ended with 1,536 deals, in our preliminary count. That’s 1% higher than 2015, which was the first year to break 1,500 transactions. Spending on deals in 2016, while not in record territory, was healthy.... Read More »